Delving into the Latest Updates on Definium Therapeutics US, Inc. with Synapse

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Ascend

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend

开始日期2026-05-10

申办/合作机构

Definium Therapeutics US, Inc.

NCT07303907

/ Recruiting临床2期

An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder

A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder

开始日期2025-12-03

申办/合作机构

Definium Therapeutics US, Inc.

NCT06941844

/ Active, not recruiting临床3期

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Emerge

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Emerge

开始日期2025-04-14

申办/合作机构

Definium Therapeutics US, Inc.

100 项与 Definium Therapeutics US, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Definium Therapeutics US, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Definium Therapeutics US, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Definium Therapeutics US, Inc. 相关的转化医学

登录后查看更多信息